Toll Free: 1-888-928-9744
Published: Sep, 2017 | Pages:
112 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the Asia-Pacific Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Human Vaccines for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Human Vaccines market competition by top manufacturers/players, with Human Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including AstraZeneca Bavarian Nordic Bharat Biotech CSL Limited Emergent BioSolutions, Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co., Inc. Mymetics Novartis AG Pfizer, Inc. Sanofi Shenzhen Kangtai Biological Products Co., Ltd. Takeda Pharmaceutical Company Limited. On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into Pneumococcal Influenza Hepatitis HPV Meningococcal Rotavirus Measles Typhoid Combination On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Human Vaccines for each application, includin Pediatrics Adolescents Adults Geriatrics If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Asia-Pacific Human Vaccines Market Report 2017 1 Human Vaccines Overview 1.1 Product Overview and Scope of Human Vaccines 1.2 Classification of Human Vaccines by Product Category 1.2.1 Asia-Pacific Human Vaccines Market Size (Sales) Comparison by Types (2012-2022) 1.2.2 Asia-Pacific Human Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Pneumococcal 1.2.4 Influenza 1.2.5 Hepatitis 1.2.6 HPV 1.2.7 Meningococcal 1.2.8 Rotavirus 1.2.9 Measles 1.2.10 Typhoid 1.2.11 Combination 1.3 Asia-Pacific Human Vaccines Market by Application/End Users 1.3.1 Asia-Pacific Human Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022) 1.3.2 Pediatrics 1.3.3 Adolescents 1.3.4 Adults 1.3.5 Geriatrics 1.4 Asia-Pacific Human Vaccines Market by Region 1.4.1 Asia-Pacific Human Vaccines Market Size (Value) Comparison by Region (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Japan Status and Prospect (2012-2022) 1.4.4 South Korea Status and Prospect (2012-2022) 1.4.5 Taiwan Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.4.7 Southeast Asia Status and Prospect (2012-2022) 1.4.8 Australia Status and Prospect (2012-2022) 1.5 Asia-Pacific Market Size (Value and Volume) of Human Vaccines (2012-2022) 1.5.1 Asia-Pacific Human Vaccines Sales and Growth Rate (2012-2022) 1.5.2 Asia-Pacific Human Vaccines Revenue and Growth Rate (2012-2022) 2 Asia-Pacific Human Vaccines Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Human Vaccines Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Human Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Asia-Pacific Human Vaccines Revenue and Share by Players/Suppliers (2012-2017) 2.2 Asia-Pacific Human Vaccines (Volume and Value) by Type 2.2.1 Asia-Pacific Human Vaccines Sales and Market Share by Type (2012-2017) 2.2.2 Asia-Pacific Human Vaccines Revenue and Market Share by Type (2012-2017) 2.3 Asia-Pacific Human Vaccines (Volume) by Application 2.4 Asia-Pacific Human Vaccines (Volume and Value) by Region 2.4.1 Asia-Pacific Human Vaccines Sales and Market Share by Region (2012-2017) 2.4.2 Asia-Pacific Human Vaccines Revenue and Market Share by Region (2012-2017) 3 China Human Vaccines (Volume, Value and Sales Price) 3.1 China Human Vaccines Sales and Value (2012-2017) 3.1.1 China Human Vaccines Sales Volume and Growth Rate (2012-2017) 3.1.2 China Human Vaccines Revenue and Growth Rate (2012-2017) 3.1.3 China Human Vaccines Sales Price Trend (2012-2017) 3.2 China Human Vaccines Sales Volume and Market Share by Type 3.3 China Human Vaccines Sales Volume and Market Share by Application 4 Japan Human Vaccines (Volume, Value and Sales Price) 4.1 Japan Human Vaccines Sales and Value (2012-2017) 4.1.1 Japan Human Vaccines Sales Volume and Growth Rate (2012-2017) 4.1.2 Japan Human Vaccines Revenue and Growth Rate (2012-2017) 4.1.3 Japan Human Vaccines Sales Price Trend (2012-2017) 4.2 Japan Human Vaccines Sales Volume and Market Share by Type 4.3 Japan Human Vaccines Sales Volume and Market Share by Application 5 South Korea Human Vaccines (Volume, Value and Sales Price) 5.1 South Korea Human Vaccines Sales and Value (2012-2017) 5.1.1 South Korea Human Vaccines Sales Volume and Growth Rate (2012-2017) 5.1.2 South Korea Human Vaccines Revenue and Growth Rate (2012-2017) 5.1.3 South Korea Human Vaccines Sales Price Trend (2012-2017) 5.2 South Korea Human Vaccines Sales Volume and Market Share by Type 5.3 South Korea Human Vaccines Sales Volume and Market Share by Application 6 Taiwan Human Vaccines (Volume, Value and Sales Price) 6.1 Taiwan Human Vaccines Sales and Value (2012-2017) 6.1.1 Taiwan Human Vaccines Sales Volume and Growth Rate (2012-2017) 6.1.2 Taiwan Human Vaccines Revenue and Growth Rate (2012-2017) 6.1.3 Taiwan Human Vaccines Sales Price Trend (2012-2017) 6.2 Taiwan Human Vaccines Sales Volume and Market Share by Type 6.3 Taiwan Human Vaccines Sales Volume and Market Share by Application 7 India Human Vaccines (Volume, Value and Sales Price) 7.1 India Human Vaccines Sales and Value (2012-2017) 7.1.1 India Human Vaccines Sales Volume and Growth Rate (2012-2017) 7.1.2 India Human Vaccines Revenue and Growth Rate (2012-2017) 7.1.3 India Human Vaccines Sales Price Trend (2012-2017) 7.2 India Human Vaccines Sales Volume and Market Share by Type 7.3 India Human Vaccines Sales Volume and Market Share by Application 8 Southeast Asia Human Vaccines (Volume, Value and Sales Price) 8.1 Southeast Asia Human Vaccines Sales and Value (2012-2017) 8.1.1 Southeast Asia Human Vaccines Sales Volume and Growth Rate (2012-2017) 8.1.2 Southeast Asia Human Vaccines Revenue and Growth Rate (2012-2017) 8.1.3 Southeast Asia Human Vaccines Sales Price Trend (2012-2017) 8.2 Southeast Asia Human Vaccines Sales Volume and Market Share by Type 8.3 Southeast Asia Human Vaccines Sales Volume and Market Share by Application 9 Australia Human Vaccines (Volume, Value and Sales Price) 9.1 Australia Human Vaccines Sales and Value (2012-2017) 9.1.1 Australia Human Vaccines Sales Volume and Growth Rate (2012-2017) 9.1.2 Australia Human Vaccines Revenue and Growth Rate (2012-2017) 9.1.3 Australia Human Vaccines Sales Price Trend (2012-2017) 9.2 Australia Human Vaccines Sales Volume and Market Share by Type 9.3 Australia Human Vaccines Sales Volume and Market Share by Application 10 Asia-Pacific Human Vaccines Players/Suppliers Profiles and Sales Data 10.1 AstraZeneca 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Human Vaccines Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 AstraZeneca Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.1.4 Main Business/Business Overview 10.2 Bavarian Nordic 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Human Vaccines Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 Bavarian Nordic Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.2.4 Main Business/Business Overview 10.3 Bharat Biotech 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Human Vaccines Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Bharat Biotech Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.3.4 Main Business/Business Overview 10.4 CSL Limited 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Human Vaccines Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 CSL Limited Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.4.4 Main Business/Business Overview 10.5 Emergent BioSolutions, Inc. 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Human Vaccines Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 Emergent BioSolutions, Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.5.4 Main Business/Business Overview 10.6 GlaxoSmithKline plc 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Human Vaccines Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 GlaxoSmithKline plc Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.6.4 Main Business/Business Overview 10.7 Johnson & Johnson 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Human Vaccines Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Johnson & Johnson Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.7.4 Main Business/Business Overview 10.8 Merck & Co., Inc. 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Human Vaccines Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 Merck & Co., Inc. Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.8.4 Main Business/Business Overview 10.9 Mymetics 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Human Vaccines Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Mymetics Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.9.4 Main Business/Business Overview 10.10 Novartis AG 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Human Vaccines Product Category, Application and Specification 10.10.2.1 Product A 10.10.2.2 Product B 10.10.3 Novartis AG Human Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 10.10.4 Main Business/Business Overview 10.11 Pfizer, Inc. 10.12 Sanofi 10.13 Shenzhen Kangtai Biological Products Co., Ltd. 10.14 Takeda Pharmaceutical Company Limited. 11 Human Vaccines Manufacturing Cost Analysis 11.1 Human Vaccines Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Human Vaccines 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Human Vaccines Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2016 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Human Vaccines Market Forecast (2017-2022) 15.1 Asia-Pacific Human Vaccines Sales Volume, Revenue and Price Forecast (2017-2022) 15.1.1 Asia-Pacific Human Vaccines Sales Volume and Growth Rate Forecast (2017-2022) 15.1.2 Asia-Pacific Human Vaccines Revenue and Growth Rate Forecast (2017-2022) 15.1.3 Asia-Pacific Human Vaccines Price and Trend Forecast (2017-2022) 15.2 Asia-Pacific Human Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.1 Asia-Pacific Human Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022) 15.2.2 Asia-Pacific Human Vaccines Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.3 China Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.4 Japan Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.5 South Korea Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.6 Taiwan Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.7 India Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.8 Southeast Asia Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.9 Australia Human Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022) 15.3 Asia-Pacific Human Vaccines Sales, Revenue and Price Forecast by Type (2017-2022) 15.3.1 Asia-Pacific Human Vaccines Sales Forecast by Type (2017-2022) 15.3.2 Asia-Pacific Human Vaccines Revenue Forecast by Type (2017-2022) 15.3.3 Asia-Pacific Human Vaccines Price Forecast by Type (2017-2022) 15.4 Asia-Pacific Human Vaccines Sales Forecast by Application (2017-2022) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer
List of Tables and Figures Figure Product Picture of Human Vaccines Figure Asia-Pacific Human Vaccines Sales Volume (K Units) by Type (2012-2022) Figure Asia-Pacific Human Vaccines Sales Volume Market Share by Type (Product Category) in 2016 Figure Pneumococcal Product Picture Figure Influenza Product Picture Figure Hepatitis Product Picture Figure HPV Product Picture Figure Meningococcal Product Picture Figure Rotavirus Product Picture Figure Measles Product Picture Figure Typhoid Product Picture Figure Combination Product Picture Figure Asia-Pacific Human Vaccines Sales (K Units) by Application (2012-2022) Figure Asia-Pacific Sales Market Share of Human Vaccines by Application in 2016 Figure Pediatrics Examples Figure Adolescents Examples Figure Adults Examples Figure Geriatrics Examples Figure Asia-Pacific Human Vaccines Market Size (Million USD) by Region (2012-2022) Figure China Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure South Korea Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Taiwan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure India Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Australia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Human Vaccines Sales Volume (K Units) and Growth Rate (2012-2022) Figure Asia-Pacific Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Human Vaccines Market Major Players Product Sales Volume (K Units)(2012-2017) Table Asia-Pacific Human Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017) Table Asia-Pacific Human Vaccines Sales Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Human Vaccines Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Human Vaccines Sales Share by Players/Suppliers Figure Asia-Pacific Human Vaccines Market Major Players Product Revenue (Million USD) 2012-2017 Table Asia-Pacific Human Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017) Table Asia-Pacific Human Vaccines Revenue Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Human Vaccines Revenue Share by Players Figure 2017 Asia-Pacific Human Vaccines Revenue Share by Players Table Asia-Pacific Human Vaccines Sales and Market Share by Type (2012-2017) Table Asia-Pacific Human Vaccines Sales Share by Type (2012-2017) Figure Sales Market Share of Human Vaccines by Type (2012-2017) Figure Asia-Pacific Human Vaccines Sales Growth Rate by Type (2012-2017) Table Asia-Pacific Human Vaccines Revenue (Million USD) and Market Share by Type (2012-2017) Table Asia-Pacific Human Vaccines Revenue Share by Type (2012-2017) Figure Revenue Market Share of Human Vaccines by Type (2012-2017) Figure Asia-Pacific Human Vaccines Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Human Vaccines Sales Volume (K Units) and Market Share by Region (2012-2017) Table Asia-Pacific Human Vaccines Sales Share by Region (2012-2017) Figure Sales Market Share of Human Vaccines by Region (2012-2017) Figure Asia-Pacific Human Vaccines Sales Market Share by Region in 2016 Table Asia-Pacific Human Vaccines Revenue (Million USD) and Market Share by Region (2012-2017) Table Asia-Pacific Human Vaccines Revenue Share (%) by Region (2012-2017) Figure Revenue Market Share of Human Vaccines by Region (2012-2017) Figure Asia-Pacific Human Vaccines Revenue Market Share by Region in 2016 Table Asia-Pacific Human Vaccines Sales Volume (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Human Vaccines Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Human Vaccines Sales Market Share by Application (2012-2017) Figure Asia-Pacific Human Vaccines Sales Market Share by Application (2012-2017) Figure China Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure China Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure China Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table China Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table China Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure China Human Vaccines Sales Volume Market Share by Type in 2016 Table China Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table China Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure China Human Vaccines Sales Volume Market Share by Application in 2016 Figure Japan Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure Japan Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table Japan Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table Japan Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure Japan Human Vaccines Sales Volume Market Share by Type in 2016 Table Japan Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table Japan Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure Japan Human Vaccines Sales Volume Market Share by Application in 2016 Figure South Korea Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure South Korea Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table South Korea Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure South Korea Human Vaccines Sales Volume Market Share by Type in 2016 Table South Korea Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table South Korea Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure South Korea Human Vaccines Sales Volume Market Share by Application in 2016 Figure Taiwan Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure Taiwan Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table Taiwan Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure Taiwan Human Vaccines Sales Volume Market Share by Type in 2016 Table Taiwan Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table Taiwan Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure Taiwan Human Vaccines Sales Volume Market Share by Application in 2016 Figure India Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure India Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure India Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table India Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table India Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure India Human Vaccines Sales Volume Market Share by Type in 2016 Table India Human Vaccines Sales Volume (K Units) by Application (2012-2017) Table India Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure India Human Vaccines Sales Volume Market Share by Application in 2016 Figure Southeast Asia Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure Southeast Asia Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table Southeast Asia Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure Southeast Asia Human Vaccines Sales Volume Market Share by Type in 2016 Table Southeast Asia Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table Southeast Asia Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure Southeast Asia Human Vaccines Sales Volume Market Share by Application in 2016 Figure Australia Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Australia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2017) Figure Australia Human Vaccines Sales Price (USD/Unit) Trend (2012-2017) Table Australia Human Vaccines Sales Volume (K Units) by Type (2012-2017) Table Australia Human Vaccines Sales Volume Market Share by Type (2012-2017) Figure Australia Human Vaccines Sales Volume Market Share by Type in 2016 Table Australia Human Vaccines Sales Volume (K Units) by Applications (2012-2017) Table Australia Human Vaccines Sales Volume Market Share by Application (2012-2017) Figure Australia Human Vaccines Sales Volume Market Share by Application in 2016 Table AstraZeneca Human Vaccines Basic Information List Table AstraZeneca Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure AstraZeneca Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure AstraZeneca Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure AstraZeneca Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Bavarian Nordic Human Vaccines Basic Information List Table Bavarian Nordic Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Bavarian Nordic Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Bavarian Nordic Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Bavarian Nordic Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Bharat Biotech Human Vaccines Basic Information List Table Bharat Biotech Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Bharat Biotech Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Bharat Biotech Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Bharat Biotech Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table CSL Limited Human Vaccines Basic Information List Table CSL Limited Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure CSL Limited Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure CSL Limited Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure CSL Limited Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Emergent BioSolutions, Inc. Human Vaccines Basic Information List Table Emergent BioSolutions, Inc. Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Emergent BioSolutions, Inc. Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Emergent BioSolutions, Inc. Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Emergent BioSolutions, Inc. Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table GlaxoSmithKline plc Human Vaccines Basic Information List Table GlaxoSmithKline plc Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure GlaxoSmithKline plc Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure GlaxoSmithKline plc Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure GlaxoSmithKline plc Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Johnson & Johnson Human Vaccines Basic Information List Table Johnson & Johnson Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Johnson & Johnson Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Johnson & Johnson Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Johnson & Johnson Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Merck & Co., Inc. Human Vaccines Basic Information List Table Merck & Co., Inc. Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Merck & Co., Inc. Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Merck & Co., Inc. Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Merck & Co., Inc. Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Mymetics Human Vaccines Basic Information List Table Mymetics Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Mymetics Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Mymetics Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Mymetics Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Novartis AG Human Vaccines Basic Information List Table Novartis AG Human Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017) Figure Novartis AG Human Vaccines Sales (K Units) and Growth Rate (2012-2017) Figure Novartis AG Human Vaccines Sales Market Share in Asia-Pacific (2012-2017) Figure Novartis AG Human Vaccines Revenue Market Share in Asia-Pacific (2012-2017) Table Pfizer, Inc. Human Vaccines Basic Information List Table Sanofi Human Vaccines Basic Information List Table Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Basic Information List Table Takeda Pharmaceutical Company Limited. Human Vaccines Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Unit) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Human Vaccines Figure Manufacturing Process Analysis of Human Vaccines Figure Human Vaccines Industrial Chain Analysis Table Raw Materials Sources of Human Vaccines Major Manufacturers in 2016 Table Major Buyers of Human Vaccines Table Distributors/Traders List Figure Asia-Pacific Human Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022) Figure Asia-Pacific Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Asia-Pacific Human Vaccines Price (USD/Unit) and Trend Forecast (2017-2022) Table Asia-Pacific Human Vaccines Sales Volume (K Units) Forecast by Region (2017-2022) Figure Asia-Pacific Human Vaccines Sales Volume Market Share Forecast by Region (2017-2022) Figure Asia-Pacific Human Vaccines Sales Volume Market Share Forecast by Region in 2022 Table Asia-Pacific Human Vaccines Revenue (Million USD) Forecast by Region (2017-2022) Figure Asia-Pacific Human Vaccines Revenue Market Share Forecast by Region (2017-2022) Figure Asia-Pacific Human Vaccines Revenue Market Share Forecast by Region in 2022 Figure China Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure China Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Japan Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure South Korea Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure South Korea Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Taiwan Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure Taiwan Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure India Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure India Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Southeast Asia Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Australia Human Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022) Figure Australia Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022) Table Asia-Pacific Human Vaccines Sales (K Units) Forecast by Type (2017-2022) Figure Asia-Pacific Human Vaccines Sales Market Share Forecast by Type (2017-2022) Table Asia-Pacific Human Vaccines Revenue (Million USD) Forecast by Type (2017-2022) Figure Asia-Pacific Human Vaccines Revenue Market Share Forecast by Type (2017-2022) Table Asia-Pacific Human Vaccines Price (USD/Unit) Forecast by Type (2017-2022) Table Asia-Pacific Human Vaccines Sales (K Units) Forecast by Application (2017-2022) Figure Asia-Pacific Human Vaccines Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.